파이로젠 시험 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 검사 유형별, 최종사용자별, 지역별, 경쟁별 세분화(2020-2030년)
Pyrogen Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By End User, By Region and Competition, 2020-2030F
상품코드:1886472
리서치사:TechSci Research
발행일:2025년 12월
페이지 정보:영문 184 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 파이로젠 시험 시장은 2024년에 15억 5,000만 달러로 평가되며, 2030년까지 CAGR 9.60%로 성장하며, 26억 9,000만 달러에 달할 것으로 예측됩니다. 발열원 시험은 의약품, 의료기기, 기타 무균 물질에 포함된 발열 물질인 발열원을 검출하고 정량화하여 발열 반응에 대한 환자의 안전을 보장하는 중요한 품질관리 프로세스입니다. 세계 발열원 시험 시장의 성장은 주로 제약 및 생명공학 분야의 R&D 활동 증가와 엄격한 제품 안전 및 품질 보증을 요구하는 세계 각국의 보건 당국의 엄격한 규제 요건에 의해 주도되고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
15억 5,000만 달러
시장 규모 : 2030년
26억 9,000만 달러
CAGR : 2025-2030년
9.60%
가장 빠르게 성장하는 부문
LAL 시험
최대 시장
북미
주요 시장 성장 촉진요인
제약 및 생명공학 산업의 확대는 세계 발열원 검사 시장의 주요 촉진요인입니다. 특히 생물제제, 첨단치료제 등 신약 개발량이 증가함에 따라 종합적인 품질관리가 필요하기 때문입니다. 이러한 분야의 견고한 성장은 제조 공정 전반에 걸쳐 제품의 안전을 보장하기 위한 발열원 검출에 대한 수요 증가와 직결되어 있습니다.
주요 시장 과제
고급 발열원 검사 장비 및 시약과 관련된 높은 비용은 세계 발열원 검사 시장의 성장을 크게 저해하고 있습니다. 이러한 재정적 장벽은 특히 소규모 조직이나 자원이 제한된 환경에서 필요한 검사 능력의 도입을 제한하고 있습니다.
주요 시장 동향
윤리적 고려, 과학적 지식의 심화, 규제 상황의 변화를 배경으로 세계 시장에서는 시험관내 발열원 검사법으로의 전환이 눈에 띄게 진행되고 있습니다. 단핵구 활성화 테스트(MAT) 및 재조합 인자 C(rFC) 분석과 같은 동물을 사용하지 않는 대체 방법은 재현성과 신뢰성을 향상시킬 뿐만 아니라 내독소 및 비내독소 발열원을 검출할 수 있는 능력을 제공합니다.
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 세계의 파이로젠 시험 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
시험 유형별(LAL 시험, 토끼 발열원시험, 단구 활성화 시험, 기타)
최종사용자별(제약·바이오테크놀러지 기업, 의료기기 기업, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 파이로젠 시험 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 파이로젠 시험 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 파이로젠 시험 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 파이로젠 시험 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 파이로젠 시험 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병·인수
제품 출시
최근 동향
제13장 세계의 파이로젠 시험 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
Merck KGaA
Genscript Corporation
Lonza Group AG
bioMerieux SA
Novo Holdings A/S
Eurofins Scientific SE
Charles River Laboratories International, Inc.
WuXi AppTec Co., Ltd.
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
The Global Pyrogen Testing Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 9.60% to reach USD 2.69 Billion by 2030. Pyrogen testing is a critical quality control process designed to detect and quantify pyrogens, fever-inducing substances, in pharmaceutical products, medical devices, and other sterile materials, thereby ensuring patient safety against febrile reactions. The global pyrogen testing market's growth is primarily driven by the increasing volume of pharmaceutical and biotechnology research and development activities, coupled with stringent regulatory mandates from health authorities worldwide that necessitate rigorous product safety and quality assurance.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1.55 Billion
Market Size 2030
USD 2.69 Billion
CAGR 2025-2030
9.60%
Fastest Growing Segment
LAL Tests
Largest Market
North America
Key Market Drivers
The expansion of the pharmaceutical and biotechnology industries constitutes a primary driver for the global pyrogen testing market, as the increasing volume of new drug development, particularly biologics and advanced therapies, necessitates comprehensive quality control. The robust growth in these sectors directly translates into a heightened demand for pyrogen detection to ensure product safety throughout the manufacturing process.
Key Market Challenges
The high cost associated with advanced pyrogen testing equipment and reagents significantly impedes the growth of the global pyrogen testing market. This financial barrier limits the adoption of necessary testing capabilities, particularly for smaller entities and in environments with constrained resources. Implementing sophisticated pyrogen testing methodologies requires substantial initial capital investment for purchasing specialized instruments and ongoing expenditure for consumables, maintenance, and skilled personnel training. Such costs can be prohibitive for small to medium-sized enterprises, which often operate with tighter budgets and fewer financial reserves compared to larger pharmaceutical corporations.
Key Market Trends
The global market is experiencing a notable shift towards in vitro pyrogen testing methods, driven by ethical considerations, increased scientific understanding, and evolving regulatory landscapes. These animal-free alternatives, such as the Monocyte Activation Test (MAT) and recombinant Factor C (rFC) assays, provide enhanced reproducibility, reliability, and the capacity to detect both endotoxin and non-endotoxin pyrogens. The adoption of these methods has been strongly supported by regulatory bodies.
Key Market Players
Merck KGaA
Genscript Corporation
Lonza Group AG
bioMerieux SA
Novo Holdings A/S
Eurofins Scientific SE
Charles River Laboratories International, Inc.
WuXi AppTec Co., Ltd.
Report Scope:
In this report, the Global Pyrogen Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pyrogen Testing Market, By Test Type:
LAL Tests
Rabbit Pyrogen Test
Monocyte Activation Test
Others
Pyrogen Testing Market, By End User:
Pharmaceutical and Biotechnology Companies
Medical Device Companies
Others
Pyrogen Testing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
South America
Brazil
Argentina
Colombia
Asia Pacific
China
India
Japan
Australia
South Korea
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Pyrogen Testing Market.
Available Customizations:
Global Pyrogen Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pyrogen Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Test Type (LAL Tests, Rabbit Pyrogen Test, Monocyte Activation Test, Others)
5.2.2. By End User (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Pyrogen Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By End User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Pyrogen Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Test Type
6.3.1.2.2. By End User
6.3.2. Canada Pyrogen Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Test Type
6.3.2.2.2. By End User
6.3.3. Mexico Pyrogen Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Test Type
6.3.3.2.2. By End User
7. Europe Pyrogen Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By End User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pyrogen Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Test Type
7.3.1.2.2. By End User
7.3.2. France Pyrogen Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Test Type
7.3.2.2.2. By End User
7.3.3. United Kingdom Pyrogen Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Test Type
7.3.3.2.2. By End User
7.3.4. Italy Pyrogen Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Test Type
7.3.4.2.2. By End User
7.3.5. Spain Pyrogen Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Test Type
7.3.5.2.2. By End User
8. Asia Pacific Pyrogen Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By End User
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Pyrogen Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Test Type
8.3.1.2.2. By End User
8.3.2. India Pyrogen Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Test Type
8.3.2.2.2. By End User
8.3.3. Japan Pyrogen Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Test Type
8.3.3.2.2. By End User
8.3.4. South Korea Pyrogen Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Test Type
8.3.4.2.2. By End User
8.3.5. Australia Pyrogen Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Test Type
8.3.5.2.2. By End User
9. Middle East & Africa Pyrogen Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By End User
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Pyrogen Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Test Type
9.3.1.2.2. By End User
9.3.2. UAE Pyrogen Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Test Type
9.3.2.2.2. By End User
9.3.3. South Africa Pyrogen Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Test Type
9.3.3.2.2. By End User
10. South America Pyrogen Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Test Type
10.2.2. By End User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pyrogen Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Test Type
10.3.1.2.2. By End User
10.3.2. Colombia Pyrogen Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Test Type
10.3.2.2.2. By End User
10.3.3. Argentina Pyrogen Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Test Type
10.3.3.2.2. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Pyrogen Testing Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Merck KGaA
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Genscript Corporation
15.3. Lonza Group AG
15.4. bioMerieux SA
15.5. Novo Holdings A/S
15.6. Eurofins Scientific SE
15.7. Charles River Laboratories International, Inc.
